Supernus bulks up its Parkinson’s portfolio with Adamas takeoverSupernus has boosted its position in central nervous system therapies with a $400 million deal to acquire Adamas Share XSupernus bulks up its Parkinson’s portfolio with Adamas takeoverhttps://pharmaphorum.com/news/supernus-bulks-up-its-parkinsons-portfolio-with-adamas-takeover/
Refining digital collaborationPharmaceutical companies are traditionally more conservative with their approach to and incorporation of new technologies; however, prior to Share XRefining digital collaborationhttps://deep-dive.pharmaphorum.com/magazine/communications-and-commercialisation/pharma-hcp-digital-collaboration/
Closing pharma’s communication gap with patientsThe pharma industry has been talking about being patient-centric for years, but often that rhetoric hasn’t been accompanied Share XClosing pharma’s communication gap with patientshttps://deep-dive.pharmaphorum.com/magazine/communications-and-commercialisation/syneos-health-pharma-patient-communications/
Leveraging a strong product launch to build a successful pharma brandSo much effort goes into ensuring the successful launch of a new pharmaceutical product or indication, but it’s Share XLeveraging a strong product launch to build a successful pharma brandhttps://deep-dive.pharmaphorum.com/magazine/communications-and-commercialisation/product-launch-build-pharma-brand/
Transform patient experience with intelligent hyper-personalisationSince 2019, pharmaceutical companies have been speeding to integrate digital channels and processes into their marketing efforts and Share XTransform patient experience with intelligent hyper-personalisationhttps://pharmaphorum.com/whitepapers/patient-experience-personalisation-indegene/
The post-pandemic evolution of pharma-doctor digital interactionsM3’s Tim Russell and Maxim Polyakov, together with Digital Futureway’s Heather Hancock, discuss new research on how doctor Share XThe post-pandemic evolution of pharma-doctor digital interactionshttps://deep-dive.pharmaphorum.com/magazine/communications-and-commercialisation/covid-pharma-doctor-digital-interactions/
Deep Dive: Communications and CommercialisationThe COVID-19 pandemic kickstarted a period of profound change in how the pharmaceutical industry approaches both communications and Share XDeep Dive: Communications and Commercialisationhttps://pharmaphorum.com/sales-marketing/deep-dive-communications-commercialisation/
Oxford Nanopore makes stellar debut on UK stock marketShares in DNA sequencing specialist Oxford Nanopore rocketed after the company made its debut on the London Stock Share XOxford Nanopore makes stellar debut on UK stock markethttps://pharmaphorum.com/news/oxford-nanopore-makes-stellar-debut-on-uk-stock-market/
Developing case-based content to engage HCPsIn this instalment of EPG Health’s HCP engagement series, Georga Cottle discusses how case-based learning connects medical theory Share XDeveloping case-based content to engage HCPshttps://pharmaphorum.com/views-and-analysis/developing-case-based-content-engage-hcps-pharma/
